BRAF and neoplasm: Together, these data demonstrate that (1) effective MAPK inhibition alone can induce tumor cell-intrinsic immune gene expression and that (2) improving the degree of MAPK inhibition achieved can increase the degree of tumor-intrinsic immune gene expression in all tumor models to the same levels observed in patients with PFS > 6 months with BRAF/MEKi.